INNOVA CAPTAB
Back to Cashflow Statement
|
INNOVA CAPTAB Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹64 Cr | ₹146 Cr | ₹67 Cr | ₹59 Cr | ₹42 Cr |
What is the latest Cash Flow from Operating Activities ratio of INNOVA CAPTAB ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹64 Cr |
| Mar2024 | ₹146 Cr |
| Mar2023 | ₹67 Cr |
| Mar2022 | ₹59 Cr |
| Mar2021 | ₹42 Cr |
How is Cash Flow from Operating Activities of INNOVA CAPTAB Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹64 Cr | -56.37 | |
| Mar2024 | ₹146 Cr | 118.01 | |
| Mar2023 | ₹67 Cr | 13.97 | |
| Mar2022 | ₹59 Cr | 41.70 | |
| Mar2021 | ₹42 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,891.9 Cr | -3.4% | -1.2% | -13.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -3.4% |
-1.2% |
-13.9% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses